Verisk terminates AccuLynx deal after FTC review misses deadline

Verisk (NASDAQ:VRSK) has terminated its definitive agreement to acquire AccuLynx after the Federal Trade Commission failed to complete its review of the transaction by the Dec. 26, 2025 termination date specified in the merger agreement.

The company said it will redeem the $1.50 billion aggregate principal amount of senior notes issued to finance the planned acquisition.

The notes will be redeemed at 101% of principal, plus accrued and unpaid interest through the redemption date, as required under a special mandatory redemption provision in the debt terms.

On a pro forma basis, assuming redemption of the notes, Verisk said its leverage as of Sept. 30, 2025 would have been about 1.9 times last-twelve-month adjusted EBITDA.

As of the same date, the company reported approximately $1.2 billion of remaining capacity under its existing share repurchase authorization.

Verisk also disclosed that AccuLynx has notified the company that it believes the termination of the merger agreement is invalid.

Verisk said it strongly disagrees with that position and intends to vigorously defend against any such claims.